News & Updates
Filter by Specialty:
NMR helps tailor treatment for smoking cessation in smokers with COPD
Among smokers with chronic obstructive pulmonary disease (COPD), use of varenicline seems better than bupropion in normal metabolizers, but bupropion displays similar efficacy and less side effects in slow metabolizers, reports a study.
NMR helps tailor treatment for smoking cessation in smokers with COPD
18 Jun 2024
Consolidation durvalumab poised to become ‘new standard’ for limited-stage SCLC
Consolidation treatment with the PD-L1 antibody durvalumab following concurrent chemoradiotherapy significantly prolonged overall (OS) and progression-free survival (PFS) in patients with limited-stage small-cell lung cancer (SCLC), as shown in the interim analysis of the phase III ADRIATIC trial.
Consolidation durvalumab poised to become ‘new standard’ for limited-stage SCLC
14 Jun 2024
Daromun plus surgery improves survival in resectable melanoma
Use of neoadjuvant daromun in addition to surgery is safe and provides survival benefits in patients with resectable, locally advanced melanoma, results of the PIVOTAL study have shown.
Daromun plus surgery improves survival in resectable melanoma
14 Jun 2024
Nivolumab plus chemo offers prolonged survival in resectable NSCLC
Patients with resectable nonsmall cell lung cancer (NSCLC) enjoy sustained survival from neoadjuvant nivolumab when added to chemotherapy compared with chemotherapy alone, as seen in the 4-year analysis from the phase III CheckMate 816 study.
